Kim Ki Hoon, Kim Su-Hyun, Hyun Jae-Won, Kim Ho Jin
Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea.
J Clin Neurol. 2022 May;18(3):280-289. doi: 10.3988/jcn.2022.18.3.280.
Antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) have recently been established as a biomarker for MOG-antibody-associated disease (MOGAD), which is a distinct demyelinating disease of the central nervous system. Among the diverse clinical phenotypes of MOGAD, myelitis is the second-most-common presentation in adults, followed by optic neuritis. While some features overlap, there are multiple reports of distinctive clinical and radiological features of MOG-IgG-associated myelitis, which are useful for differentiating MOGAD from both multiple sclerosis and neuromyelitis optica spectrum disorder. In this review we summarize the clinical and radiographic characteristics of MOG-IgG-associated myelitis with a particular focus on adult patients.
抗髓鞘少突胶质细胞糖蛋白(MOG-IgG)抗体最近已被确立为MOG抗体相关疾病(MOGAD)的生物标志物,MOGAD是一种中枢神经系统的独特脱髓鞘疾病。在MOGAD的多种临床表型中,脊髓炎是成人中第二常见的表现,其次是视神经炎。虽然有些特征重叠,但有多项报告指出了MOG-IgG相关脊髓炎独特的临床和放射学特征,这些特征有助于将MOGAD与多发性硬化症和视神经脊髓炎谱系障碍区分开来。在本综述中,我们总结了MOG-IgG相关脊髓炎的临床和影像学特征,特别关注成年患者。